TRANSDERMAL TESTOSTERONE SUBSTITUTION THERAPY FOR MALE HYPOGONADISM
- 1 October 1986
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 328 (8513) , 943-946
- https://doi.org/10.1016/s0140-6736(86)90600-8
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal menActa Endocrinologica, 1983
- Therapeutic efficacy of a new transdermal system containing nitroglycerin in patients with angina pectorisEuropean Journal of Clinical Pharmacology, 1982
- Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal menFertility and Sterility, 1982
- Transdermal drug administration--a nuisance becomes an opportunity.BMJ, 1981
- ANDROGEN REPLACEMENT WITH ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MEN: A DOUBLE BLIND CONTROLLED STUDYClinical Endocrinology, 1981
- Comparison of Testosterone, Dihydrotestosterone, Luteinizing Hormone, and Follicle-Stimulating Hormone in Serum after Injection of Testosterone Enanthate or Testosterone CypionateFertility and Sterility, 1980
- Long‐Term Study of Oral Testosterone Undecanoate in Hypogonadal MalesInternational Journal of Andrology, 1978
- Influence of sex, testicular development and liver function on the bioavailability of oral testosteroneEuropean Journal of Clinical Investigation, 1977
- Bioavailability and LH-Suppressing Effect of Different Testosterone Preparations in Normal and Hypogonadal MenHormone Research, 1976
- PLASMA ANDROGEN LEVELS IN MEN AFTER ORAL ADMINISTRATION OF TESTOSTERONE OR TESTOSTERONE UNDECANOATEActa Endocrinologica, 1975